Method and compositions useful in preventing equine influenza
US4920213A · kind A · utility
71Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 1986 |
| Grant date | Apr 24, 1990 |
| Priority date | — |
| Expiry date | Jul 21, 2006 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant vaccines for immunizing horses against equine influenza virus (EIV) are disclosed. The DNA sequences encoding the hemagglutinin (HA) and neuraminidase (NA) glycoproteins from the two strains of EIV currently infective in horses are used to construct vaccinia carried vaccines, to design synthetic peptides for primer and booster administration, and to permit recombinant synthesis of HA and/or NA protein based vaccines. These DNA sequences also provide probes useful for preparing similar vaccines from fresh isolates of new strains generated by genetic drift.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.